A century of pneumococcal vaccination research in humans

JD Grabenstein, KP Klugman - Clinical microbiology and …, 2012 - Wiley Online Library
Clin Microbiol Infect 2012; 18 (Suppl. 5): 15–24 Abstract Sir Almroth Wright coordinated the
first trial of a whole‐cell pneumococcal vaccine in South Africa from 1911 to 1912. Wright …

[HTML][HTML] Acute organ injury and long-term sequelae of severe pneumococcal infections

KL Kruckow, K Zhao, DME Bowdish, CJ Orihuela - Pneumonia, 2023 - Springer
Streptococcus pneumoniae (Spn) is a major public health problem, as it is a main cause of
otitis media, community-acquired pneumonia, bacteremia, sepsis, and meningitis. Acute …

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis

P Scott, AWS Rutjes, L Bermetz, N Robert, S Scott… - Vaccine, 2011 - Elsevier
BACKGROUND: Pneumococcal conjugate vaccines (PCV) were first licensed for use with 3
primary doses in infancy and a booster dose. The evidence for the effects of different …

Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany

G Falkenhorst, C Remschmidt, T Harder, O Wichmann… - 2016 - Springer
The incidence of pneumococcal diseases among adults increases with age. Therefore,
Germany's Standing Committee on Vaccination (Ständige Impfkommission, STIKO) has …

Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia

J Dower, M Donald, N Begum, S Vlack, I Ozolins - Vaccine, 2011 - Elsevier
Using findings from a random, computer assisted telephone survey of households, this
paper examines influenza and pneumococcal immunisation coverage and predictors of …

Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study

RC Hechter, C Chao, SJ Jacobsen, JM Slezak… - Vaccine, 2012 - Elsevier
OBJECTIVE: To examine the effectiveness of pneumococcal polysaccharide vaccine (PPV)
among approximately 40,000 community-dwelling men aged 45years and older in the …

Guidelines and quality measures: do they improve outcomes of patients with community-acquired pneumonia?

J Johnstone, L Mandell - Infectious Disease Clinics, 2013 - id.theclinics.com
Guidelines Each year more than $50 billion are spent on biomedical research and more
than 15,000 trials are reported, often with a bias against reporting results with negative …

Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination

A Vila‐Córcoles - Journal of internal medicine, 2009 - Wiley Online Library
Streptococcus pneumoniae is an important cause of morbidity and mortality worldwide.
There are three established approaches to anti‐pneumococcal vaccination: capsular …

Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory …

S Moberley, V Krause, H Cook, K Mulholland… - Vaccine, 2010 - Elsevier
Over the last decade, there has been no discernible reduction in Invasive Pneumococcal
Disease (IPD) amongst Indigenous adults in the Northern Territory (NT) of Australia, despite …

[PDF][PDF] Prevención de las enfermedades infecciosas

PA Herce, CB Martínez, EC Bertrán, JJG Marco… - Atención …, 2014 - core.ac.uk
La administración de vacunas constituye una de las actividades preventivas más coste-
efectivas de las que se dispone y una de las medidas que más ha contribuido a la …